Shenzhen Informer

BGI-Shenzhen Again Extends Tender Offer For Complete Genomics To March 14 (RTTNews.com) – BGI-Shenzhen announced that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics Inc. ( GNOM ) to 11:59 … Read more on NASDAQ

Read the full story

BGI-Shenzhen Completes Tender Offer for Complete Genomics New York City Mayor Michael Bloomberg stopped by the new site of the New York Genome Center at 101 Sixth Avenue in Manhattan on Tuesday. While the center did lose out on the $ 100 million genius school grant last year, Bloomberg dug into his own … Read [...]

Read the full story

BGI-Shenzhen Successfully Completes Tender Offer For Complete Genomics, Inc. SHENZHEN, China, March 15, 2013 /PRNewswire/ — BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has successfully completed its all cash tender offer (the "Offer") to purchase all … Read more on PR Newswire (press release)

Read the full story

BGI Shenzhen Tenders Offer for Complete Genomics BGI-Shenzhen announced that it would extend an all cash offer to purchase all outstanding shares of common stock for Complete Genomics Inc. The tender offer was made through BGI-Shenzhen's wholly owned subsidiary Beta Acquisition Corporation. Read more on IVCPOST

Read the full story

BGI-Shenzhen Extends Tender Offer For Complete Genomics To Mar. 1 (RTTNews.com) – BGI-Shenzhen said Friday that it, through its wholly-owned subsidiary Beta Acquisition Corp., has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics, Inc. ( GNOM ) to March 1. Read more on NASDAQ

Read the full story

BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc. SHENZHEN, China, Feb. 6, 2013 /PRNewswire/ — BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of … Read more on PR Newswire (press release)

Read the full story

BGI-Shenzhen Extends Tender Offer For Complete Genomics (RTTNews.com) – BGI-Shenzhen said Friday that it, through its wholly-owned subsidiary Beta Acquisition Corp., has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics, Inc. ( GNOM ) to February 1. Read more on NASDAQ

Read the full story

BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc. SHENZHEN, China, Jan. 25, 2013 /PRNewswire/ — BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of … Read more on PR Newswire (press release)

Read the full story

BGI-Shenzhen Announces an Additional Extension of Tender Offer for Complete … BGI-Shenzhen ("BGI") announced Friday that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: … Read more on Benzinga

Read the full story

BGI-Shenzhen Announces Extension of Tender Offer For Complete Genomics BGI-Shenzhen ("BGI") announced today that it, through its wholly owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: … Read more on Benzinga

Read the full story

BGI-Shenzhen Extends Tender Offer For Complete Genomics to December 14 … BGI-Shenzhen announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) … Read more on Benzinga

Read the full story

Illumina Says It Was Second Bidder for Complete Genomics BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics in September for $ 3.15 a share, or about $ 117.6 million, to expand in the U.S. market for medical and research DNA testing. The board of Complete … Read more on Bloomberg

Read the full story

BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc. SHENZHEN, China, Oct. 22, 2012 — /PRNewswire/ — BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of … Read more on The Herald | HeraldOnline.com

Read the full story

BGI-Shenzhen Commences Tender Offer To Buy Complete Genomics – Quick … BGI-Shenzhen, or BGI, said it is commencing, through its wholly owned subsidiary Beta Acquisition Corp., a cash tender offer to purchase all outstanding shares of common stock of Complete Genomics, Inc. (GNOM: Quote). After successful closing of the … Read more on RTT News

Read the full story

BGI-Shenzhen Commences Tender Offer To Buy Complete Genomics – Quick … (RTTNews.com) – BGI-Shenzhen, or BGI, said it is commencing, through its wholly owned subsidiary Beta Acquisition Corp., a cash tender offer to purchase all outstanding shares of common stock of Complete Genomics, Inc. (GNOM). After successful closing … Read more on NASDAQ

Read the full story